Managing Biotechnology : From Science to Market in the Connected Age

Managing Biotechnology: From Science to Market in the Digital Age -- Contents -- Foreword -- Preface -- Book Structure -- Research Methodology -- Acknowledgments -- PRAISE for Managing Biotechnology: From Science to Market in the Digital Age -- About the Authors -- Françoise Simon -- Glen Giovannetti -- Part 1: New Models For Networked Innovation -- Chapter 1: Digital Evolution of Biotechnology -- Industry Applications -- Impact of Megatrends -- Digital Health Opportunities -- Infotechnology Initiatives in Healthcare -- Disruption Risk From Infotech -- Technology Strategies -- Rise and Limitations of Wearables -- New Entrants -- Big Infotech Strategies -- Apple: Building a Consumer Ecosystem -- Qualcomm: From Chips to Health Ventures -- IBM: From Hardware to Software and Cloud Services -- Alphabet: Expanding a Healthcare Portfolio -- Conclusion -- Summary Points -- Chapter 2: Biotechnology Financing Strategies -- The Long Game -- Passing the Baton -- Strategic Decisions -- How Much Capital to Raise -- Pricing and Dilution -- When to Raise Capital -- Adaptations to Preserve Capital -- Geographic Considerations -- Sources of Financing -- Seed Capital -- Venture Capital -- Corporate Venture Capital -- Venture Debt -- Crossover Investors -- Public Investors: The IPO Process -- Government Grants and Disease Foundations -- Strategic Alliances -- Asset-Based Financing -- A Word About Mergers and Acquisitions -- Summary Points -- Chapter 3: Success Through Collaboration -- Alliance Evolution: More Players and New Structures -- Strategic Alliances: A Stalwart of the Biopharma Industry -- Alliance Versus Acquisition -- Structure Considerations to Maximize Value -- Divesting for Focus -- Doing the Deal -- Partner Selection -- Mission and Objectives -- Structure -- Key Deal Terms -- Relationships Matter -- Monitoring Results and Learning -- Summary Points